Recent Articles

August 21, 2017 9:08 am
Andrea Toel, Senior Product Manager, Lonza
Here we explore how the development of cancer immunotherapies has started to focus on improving efficiency, safety, and specificity by using genetic engineering approaches.
August 7, 2017 11:17 am
Michelle Taylor, Editor-in-Chief, Laboratory Equipment
A major trend that emerged from Deloitte’s research is the life science industry’s shift from traditional asset-based partnerships to collaborative, non-asset-based R&D partnerships.
July 26, 2017 10:48 am
Lauren Scrudato
Researchers have taken a huge leap toward personalized medicine with the development of a revolutionary model of the female reproductive system that can more accurately test drugs and help scientists better understand diseases of the female reproductive tract.
July 27, 2017 7:30 am
Bevin Fletcher
Interim results from a 4-year PET scan study suggest that a significant number of patients being treated for Alzheimer’s disease may not actually have it at all.
July 31, 2017 8:50 am
Darren Barrington-Light, Informatics & Chromatography Software, Thermo Fisher Scientific
Data integrity has long played an important role in pharmaceutical production, with robust data collection and storage fundamental to the concept of Good Manufacturing Practice (GMP).
July 24, 2017 9:32 am
Stuart Ward, Head of Business Analysis, IDBS
With organizations increasingly trying to do more whilst cutting costs, do they risk cutting corners on safety?
July 17, 2017 11:18 am
Chad Clark, President, Precision for Medicine and Scott Marshall, Managing Director of Biomarker and IVD Analytics, Precision for Medicine
Delivering on the promise of precision medicine requires new approaches and informatics platforms to address new challenges.
June 30, 2017 11:31 am
Rob Johnson
Biology researchers tap machine learning to gain knowledge which may lead to futuristic medical treatments.
June 26, 2017 10:45 am
Jae Chung, Founder and President, goBalto
There is no doubt that technology solutions help both sponsors and contract research organizations (CROs) improve operational efficiencies and facilitate decision making. While one would expect to hear a similar story from all stakeholders involved in clinical trials, a recent survey suggests that these technologies are having the opposite effect at investigative sites - adding to what is already a heavy workload burden.
Subscribe to Bioscience Technology